SAM
CNMD icon

Smartleaf Asset Management’s CONMED CNMD Stock Holding History

Smartleaf Asset Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.9K Sell
324
-271
-46% -$11K ﹤0.01% 2285
2025
Q4 		$24.5K Buy
595
+78
+15% +$3.39K ﹤0.01% 1923
2025
Q3 		$23.6K Sell
517
-1,445
-74% -$74.9K ﹤0.01% 1744
2025
Q2 		$102K Sell
1,962
-298
-13% -$16.4K 0.01% 850
2025
Q1 		$133K Buy
2,260
+298
+15% +$19.2K 0.01% 721
2024
Q4 		$136K Buy
1,962
+322
+20% +$22.4K 0.01% 699
2024
Q3 		$123K Buy
1,640
+1,542
+1,573% +$109K 0.01% 645
2024
Q2 		$6.62K Buy
98
+47
+92% +$3.43K ﹤0.01% 1653
2024
Q1 		$4.09K Buy
51
+49
+2,450% +$4.37K ﹤0.01% 1284
2023
Q4 		$0 Buy
+2
New +$207 ﹤0.01% 1149

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Smartleaf Asset Management's CNMD Position: Q1 2026 in Review

Smartleaf Asset Management reduced its CONMED (CNMD) stake by 46% in Q1 2026, selling an estimated $11K and leaving 324 shares worth $10.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2285.

Smartleaf Asset Management first reported a position in CNMD in Q4 2023 and has held it in 10 quarters since. The position peaked at $136K in Q4 2024. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Smartleaf Asset Management held 324 shares of CONMED worth $10.9K as of Q1 2026.
  • Smartleaf Asset Management sold 271 CONMED shares in Q1 2026, an estimated $11K.
  • CONMED made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #2285 holding.
  • Smartleaf Asset Management first reported a position in CONMED in Q4 2023 and has held it in 10 quarters since.
  • Smartleaf Asset Management's CONMED position peaked at $136K in Q4 2024.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.